Clinical Trial Update: Assessment of Olfactory Dysfunction in SARS CoV-2 (COVID-19) Infection

View source ↗

Summary

A completed clinical trial assessing olfactory dysfunction in COVID-19 patients, focusing on loss of smell and related quality-of-life impacts.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anosmia
• Olfactory Disorders

Snippet

Sponsor: Cambridge University Hospitals NHS Foundation Trust | Conditions: Olfactory Disorder, COVID19 | Status: COMPLETED